Literature DB >> 27148860

14q13 distal microdeletion encompassing NKX2-1 and PAX9: Patient report and refinement of the associated phenotype.

Mattia Gentile1, Delia De Mattia2, Angela Pansini1, Federico Schettini2, Antonia Lucia Buonadonna1, Manuela Capozza2, Romina Ficarella1, Nicola Laforgia2.   

Abstract

Chromosome 14q11-q22 deletion syndrome (OMIM 613457) is a rare genomic disorder whose associated phenotype is heterogeneous, depending on the size, and, mostly, on the deleted region. We report the clinical and molecular characterization of a female newborn, whose phenotype was characterized by poor growth, dysmorphic facial features, subclinical hypothyroidism, and mild reduction of CD3CD8 Lymphocytes with increased CD4/CD8 ratio. By array-CGH, we identified a 4.08 de novo interstitial deletion of the 14q13.2q21.1 region, which includes 16 OMIM genes.Our patient phenotype is compared with other published cases, for a better classification of the 14q11-q22 deletion syndrome. We demonstrated that the 14q13.2q21.1 deletion, which encompasses NKX2-1, but not FOXG1 gene and HPE8 region, identifies a well defined, more benign, microdeletion syndrome. This report confirms that an early identification with accurate characterization of the genomic disorders is of great relevance, enabling proper genetic counseling of the reproductive risk, as well as disease prognosis, and patient management.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  14q13 microdeletion; CAHTP syndrome; NKX2-1; PAX9; chromosome 14 deletion; genotype-phenotype

Mesh:

Substances:

Year:  2016        PMID: 27148860     DOI: 10.1002/ajmg.a.37691

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  2 in total

Review 1.  14q12q13.2 microdeletion syndrome: Clinical characterization of a new patient, review of the literature, and further evidence of a candidate region for CNS anomalies.

Authors:  Emanuela Ponzi; Mattia Gentile; Emanuele Agolini; Emilia Matera; Roberto Palumbi; Antonia Lucia Buonadonna; Antonia Peschechera; Alessandra Gabellone; Maria Fatima Antonucci; Lucia Margari
Journal:  Mol Genet Genomic Med       Date:  2020-05-16       Impact factor: 2.183

2.  A novel 14q13.1-21.1 deletion identified by CNV-Seq in a patient with brain-lung-thyroid syndrome, tooth agenesis and immunodeficiency.

Authors:  Xuyun Hu; Jun Liu; Ruolan Guo; Jun Guo; Zhipeng Zhao; Wei Li; Baoping Xu; Chanjuan Hao
Journal:  Mol Cytogenet       Date:  2019-12-19       Impact factor: 2.009

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.